Pretreatment level of serum sialic acid predicts both qualitative and quantitative bone metastases of prostate cancer
CORRECTION article
Corrigendum: Pretreatment level of serum sialic acid predicts both qualitative and quantitative bone metastases of prostate cancer
Provisionally accepted- 1 Department of Urology, Qilu Hospital, Shandong University, Jinan, China
- 2 Department of Respiratory and Critical Care Medicine, Qilu Hospital, Shandong University, Jinan, Shandong Province, China
- 3 Department of Urology, Yucheng People’s Hospital, Dezhou, China, Dezhou, China
Keywords: Serum sialic acid, Bone Metastases, prostate cancer, Low-volume disease, High-volume disease
Received: 17 Jul 2024; Accepted: 23 Jul 2024.
Copyright: © 2024 Sun, Tian, Wang, Jing, Qiu, Cui, Liu, Liu, Yan and Li. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Dawei Li, Department of Urology, Qilu Hospital, Shandong University, Jinan, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.